Literature DB >> 14998169

Proteomic analysis of human ventricular cerebrospinal fluid from neurologically normal, elderly subjects using two-dimensional LC-MS/MS.

Brett R Wenner1, Mark A Lovell, Bert C Lynn.   

Abstract

A two-dimensional liquid chromatography separation scheme coupled to tandem mass spectrometry (2-D LC-MS/MS) was utilized to profile the proteome of human CSF. Ventricular CSF samples acquired post-mortem from 10 cognitively normal elderly subjects (mean +/- SEM Braak stage = 1.7 +/- 0.2) were analyzed to determine their protein composition. Raw CSF samples were subjected to an immunobased processing method to remove highly abundant albumin and immunoglobulin (Ig), allowing better detection of lower-abundance proteins. Samples were subjected to trypsin proteolysis followed by C18 solid-phase extraction. Tryptic CSF peptides were separated using a 2-D LC column, in which both strong cation exchange (SCX) and C18 phases were packed into a single capillary. MS/MS spectra of CSF peptides were searched against a human sub-database of the NBCI nonredundant database using the SEQUEST algorithm. Search results were further filtered using DTAselect, and individual samples were compared to one another using Contrast. Using this method, we were able to unambiguously identify 249 CSF proteins from 10 subjects. Of these proteins, 38% were unique to individual subjects, whereas only 6% were common to all 10 subjects. These results suggest considerable subject-to-subject variability in the CSF proteome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998169     DOI: 10.1021/pr034070r

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  17 in total

1.  Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array.

Authors:  Geoffrey S Baird; Sally K Nelson; Tracy R Keeney; Alex Stewart; Stephen Williams; Stephan Kraemer; Elaine R Peskind; Thomas J Montine
Journal:  Am J Pathol       Date:  2011-11-26       Impact factor: 4.307

Review 2.  Proteomics of human neurodegenerative diseases.

Authors:  Jing Zhang; C Dirk Keene; Catherine Pan; Kathleen S Montine; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

3.  Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.

Authors:  Robert Cunningham; Di Ma; Lingjun Li
Journal:  Front Biol (Beijing)       Date:  2012-08-01

4.  Quantitative proteomic analyses of cerebrospinal fluid using iTRAQ in a primate model of iron deficiency anemia.

Authors:  Stephanie M Patton; Christopher L Coe; Gabriele R Lubach; James R Connor
Journal:  Dev Neurosci       Date:  2012-09-26       Impact factor: 2.984

Review 5.  Human body fluid proteome analysis.

Authors:  Shen Hu; Joseph A Loo; David T Wong
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

6.  Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.

Authors:  Alberto Lleó; Raúl Núñez-Llaves; Daniel Alcolea; Cristina Chiva; Daniel Balateu-Paños; Martí Colom-Cadena; Gemma Gomez-Giro; Laia Muñoz; Marta Querol-Vilaseca; Jordi Pegueroles; Lorena Rami; Albert Lladó; José L Molinuevo; Mikel Tainta; Jordi Clarimón; Tara Spires-Jones; Rafael Blesa; Juan Fortea; Pablo Martínez-Lage; Raquel Sánchez-Valle; Eduard Sabidó; Àlex Bayés; Olivia Belbin
Journal:  Mol Cell Proteomics       Date:  2019-01-03       Impact factor: 5.911

7.  Establishing the proteome of normal human cerebrospinal fluid.

Authors:  Steven E Schutzer; Tao Liu; Benjamin H Natelson; Thomas E Angel; Athena A Schepmoes; Samuel O Purvine; Kim K Hixson; Mary S Lipton; David G Camp; Patricia K Coyle; Richard D Smith; Jonas Bergquist
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

Review 8.  Biomarker discovery in neurodegenerative diseases: a proteomic approach.

Authors:  Min Shi; W Michael Caudle; Jing Zhang
Journal:  Neurobiol Dis       Date:  2008-09-26       Impact factor: 5.996

9.  Biomarkers in the clinical diagnosis and management of traumatic brain injury.

Authors:  Georgene W Hergenroeder; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

10.  Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Michael Malek-Ahmadi; Tyler A Kokjohn; Brittany N Dugger; Douglas G Walker; Holly A Shill; Sandra A Jacobson; Marwan N Sabbagh; Alex E Roher
Journal:  Biomark Insights       Date:  2013-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.